WallStreetZenWallStreetZen

NASDAQ: CTXR
Citius Pharmaceuticals Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Citius Pharmaceuticals earnings were -$37.4M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest CTXR earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$8.0M, down 9.4% from last quarter. For the last reported fiscal year 2025 ending Sep 30, 2025, CTXR reported annual earnings of -$37.4M, with -6.8% growth.

CTXR earnings history

Current Revenue
$0.0
Current Earnings
-$37.4M
Current Profit Margin
0%

CTXR Return on Equity

Current Company
-57.9%
Current Industry
-21.2%
Current Market
35.1%
CTXR's Return on Equity (-57.9%)... subscribe to Premium to read more.
High Return on Equity Performance

CTXR Return on Assets

Current Company
-29.9%
Current Industry
-8.8%
CTXR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CTXR announces earnings.

CTXR Return on Capital Employed

Current Company
-41.98%
Current Industry
-3.5%
CTXR's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CTXR vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CTXR-$35.89M-$37.43MN/A-$3.38
OSRHN/AN/AN/AN/A
ALLR-$15.13M-$15.31M-99.82%$9.09
BCAB-$64.13M-$64.71MN/A-$1.15
LIMNN/AN/AN/AN/A
View Top Biotech Stocks

Citius Pharmaceuticals Earnings Reports & History FAQ

What were Citius Pharmaceuticals's earnings last quarter?

Citius Pharmaceuticals (NASDAQ: CTXR) reported Q3 2025 earnings per share (EPS) of -$0.11, up 93.13% year over year. Total CTXR earnings for the quarter were -$7.96 million. In the same quarter last year, Citius Pharmaceuticals's earnings per share (EPS) was -$1.60.

If you're new to stock investing, here's how to buy Citius Pharmaceuticals stock.

Is Citius Pharmaceuticals profitable or losing money?

As of the last Citius Pharmaceuticals earnings report, Citius Pharmaceuticals is currently losing money. Citius Pharmaceuticals's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$37.43 million, a 4.36% decrease year over year.

What was CTXR's earnings growth in the past year?

As of Citius Pharmaceuticals's earnings date in Q1 2026, Citius Pharmaceuticals's earnings has grown year over year. CTXR earnings in the past year totalled -$37.43 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.